Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujia Dai

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of Experimental Botany|July 9, 2018
DA-6 promotes germination and seedling establishment from aged soybean seeds by mediating fatty acid metabolism and glycometabolismWenguan Zhou, Feng Chen, Sihua Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Indole amide hydroxamic acids as potent inhibitors of histone deacetylasesYujia Dai, Yan Guo, Jun Guo, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2011
Discovery of potent and selective thienopyrimidine inhibitors of Aurora kinasesWilliam J McClellan, Yujia Dai, Cele Abad-Zapatero, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2012
Exploration of diverse hinge-binding scaffolds for selective Aurora kinase inhibitorsZhiqin Ji, Yujia Dai, Cele Abad-Zapatero, et al.
Journal of Integrative Plant Biology|February 8, 2024
PIF4 interacts with ABI4 to serve as a transcriptional activator complex to promote seed dormancy by enhancing ABA biosynthesis and signalingXiaofeng Luo, Yujia Dai, Baoshan Xian, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitorsYujia Dai, Kresna Hartandi, Niru B Soni, et al.
Journal of Medicinal Chemistry|January 5, 2002
Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitorsCarol K Wada, James H Holms, Michael L Curtin, et al.
Blood|January 9, 2007
ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemiaDeepa B Shankar, Junling Li, Paul Tapang, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2018
Discovery and optimization of novel constrained pyrrolopyridone BET family inhibitorsSteven D Fidanze, Dachun Liu, Robert A Mantei, et al.
Molecular Cancer Therapeutics|May 2, 2006
Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitorDaniel H Albert, Paul Tapang, Terrance J Magoc, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Experimental Botany|July 9, 2018
DA-6 promotes germination and seedling establishment from aged soybean seeds by mediating fatty acid metabolism and glycometabolismWenguan Zhou, Feng Chen, Sihua Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Indole amide hydroxamic acids as potent inhibitors of histone deacetylasesYujia Dai, Yan Guo, Jun Guo, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2011
Discovery of potent and selective thienopyrimidine inhibitors of Aurora kinasesWilliam J McClellan, Yujia Dai, Cele Abad-Zapatero, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2012
Exploration of diverse hinge-binding scaffolds for selective Aurora kinase inhibitorsZhiqin Ji, Yujia Dai, Cele Abad-Zapatero, et al.
Journal of Integrative Plant Biology|February 8, 2024
PIF4 interacts with ABI4 to serve as a transcriptional activator complex to promote seed dormancy by enhancing ABA biosynthesis and signalingXiaofeng Luo, Yujia Dai, Baoshan Xian, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitorsYujia Dai, Kresna Hartandi, Niru B Soni, et al.
Journal of Medicinal Chemistry|January 5, 2002
Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitorsCarol K Wada, James H Holms, Michael L Curtin, et al.
Blood|January 9, 2007
ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemiaDeepa B Shankar, Junling Li, Paul Tapang, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2018
Discovery and optimization of novel constrained pyrrolopyridone BET family inhibitorsSteven D Fidanze, Dachun Liu, Robert A Mantei, et al.
Molecular Cancer Therapeutics|May 2, 2006
Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitorDaniel H Albert, Paul Tapang, Terrance J Magoc, et al.
Pageof 4